U.S. Food and Drug Administration (FDA)

ATTORNEY GENERAL BONTA URGES FDA TO ADDRESS DANGEROUS PULSE OXIMETER INACCURACIES IMPACTING COMMUNITIES OF COLOR

Source: California Attorney General’s office

Image: CC via Bing

November 1, 2023 (Sacramento) -- California Attorney General Rob Bonta, leading a multistate coalition of 25 attorneys general, today submitted a letter to urge the U.S. Food and Drug Administration (FDA) to strengthen guidance and provide clear warning labels regarding incorrect pulse oximeter readings for patients of color.


Error message

Support community news in the public interest! As nonprofit news, we rely on donations from the public to fund our reporting -- not special interests. Please donate to sustain East County Magazine's local reporting and/or wildfire alerts at https://www.eastcountymedia.org/donate to help us keep people safe and informed across our region.

FRANKENFISH? GMO SALMON TESTED SHOW HIGH ALLERGY POTENCY

 

Consumer group starts petition to urge more review

By Miriam Raftery

Photo: GMO salmon (back) is larger than non-GMO salmon of same age

May 2, 2015 (Washington D.C.)  -- The U.S. Food and Drug Administration (FDA) is considering approving a genetically modified salmon – not as a food, but as an “animal drug,” according to Sarah Alexander at Food and Water Watch.  If approved, it would be the first GMO animal allowed into our food chain. But tests have found high levels of both hormone and potential allergens.  Only six fish were tested for allergies – but those fish had an allergenic potency was 20 to 50 percent higher in the GMO salmon than non-GMO salmon.


Error message

Support community news in the public interest! As nonprofit news, we rely on donations from the public to fund our reporting -- not special interests. Please donate to sustain East County Magazine's local reporting and/or wildfire alerts at https://www.eastcountymedia.org/donate to help us keep people safe and informed across our region.

FDA SEEKS LARGER TRIAL OF PROMISING DRUG TO TREAT MUSCULAR DYSTROPHY

 

By Miriam Raftery

April 21, 2014 (Washington D.C.) --The U.S. Food and Drug Administration, or FDA, is on the verge of approving the first-ever drug treatment for a severe form of muscular dystrophy.  Duchenne muscular dystrophy is a deadly disease that typically  leaves its victims in wheelchairs by their teens and dead in their 20s, according to the U.S. Human Genome Institute.  This disease strikes one in every 3500 boys worldwide.


Error message

Support community news in the public interest! As nonprofit news, we rely on donations from the public to fund our reporting -- not special interests. Please donate to sustain East County Magazine's local reporting and/or wildfire alerts at https://www.eastcountymedia.org/donate to help us keep people safe and informed across our region.

Weddings in East County

Hot Coupons